412 related articles for article (PubMed ID: 16044141)
1. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres.
Windrum P; Morris TC; Drake MB; Niederwieser D; Ruutu T;
Bone Marrow Transplant; 2005 Oct; 36(7):601-3. PubMed ID: 16044141
[TBL] [Abstract][Full Text] [Related]
2. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
[TBL] [Abstract][Full Text] [Related]
3. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
[TBL] [Abstract][Full Text] [Related]
4. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO.
Lakota J; Fuchsberger P
Bone Marrow Transplant; 1996 Jul; 18(1):262-3. PubMed ID: 8832035
[No Abstract] [Full Text] [Related]
5. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.
Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C
Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892
[TBL] [Abstract][Full Text] [Related]
7. Quantification of residual dimethylsulfoxide after washing cryopreserved stem cells and thawing tissue grafts.
Decot V; Houzé P; Stoltz JF; Bensoussan D
Biomed Mater Eng; 2009; 19(4-5):293-300. PubMed ID: 20042796
[TBL] [Abstract][Full Text] [Related]
8. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells.
Smagur A; Mitrus I; Giebel S; Sadus-Wojciechowska M; Najda J; Kruzel T; Czerw T; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Holowiecki J
Vox Sang; 2013 Apr; 104(3):240-7. PubMed ID: 23046417
[TBL] [Abstract][Full Text] [Related]
9. The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity.
Syme R; Bewick M; Stewart D; Porter K; Chadderton T; Glück S
Biol Blood Marrow Transplant; 2004 Feb; 10(2):135-41. PubMed ID: 14750079
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing.
Rodríguez L; Velasco B; García J; Martín-Henao GA
Transfusion; 2005 Aug; 45(8):1391-7. PubMed ID: 16078930
[TBL] [Abstract][Full Text] [Related]
11. Cryopreserved stem cell products containing dimethyl sulfoxide lead to activation of the coagulation system without any impact on engraftment.
Holbro A; Graf L; Topalidou M; Bucher C; Passweg JR; Tsakiris DA
Transfusion; 2014 Jun; 54(6):1508-14. PubMed ID: 24304039
[TBL] [Abstract][Full Text] [Related]
12. Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells.
Scheinkönig C; Kappicht S; Kolb HJ; Schleuning M
Bone Marrow Transplant; 2004 Sep; 34(6):531-6. PubMed ID: 15286692
[TBL] [Abstract][Full Text] [Related]
13. Effect of dimethyl sulfoxide (DMSO) on cryopreservation of porcine mesenchymal stem cells (pMSCs).
Ock SA; Rho GJ
Cell Transplant; 2011; 20(8):1231-9. PubMed ID: 21294964
[TBL] [Abstract][Full Text] [Related]
14. The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of marrow repopulating ability.
Balint B; Ivanović Z; Petakov M; Taseski J; Jovcić G; Stojanović N; Milenković P
Bone Marrow Transplant; 1999 Mar; 23(6):613-9. PubMed ID: 10217193
[TBL] [Abstract][Full Text] [Related]
15. Aseptic vitrification of human germinal vesicle oocytes using dimethyl sulfoxide as a cryoprotectant.
Isachenko V; Montag M; Isachenko E; Dessole S; Nawroth F; van der Ven H
Fertil Steril; 2006 Mar; 85(3):741-7. PubMed ID: 16500347
[TBL] [Abstract][Full Text] [Related]
16. Fractionated infusions of cryopreserved stem cells may prevent DMSO-induced major cardiac complications in graft recipients.
Martino M; Morabito F; Messina G; Irrera G; Pucci G; Iacopino P
Haematologica; 1996; 81(1):59-61. PubMed ID: 8900855
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
18. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood.
Meyer TP; Hofmann B; Zaisserer J; Jacobs VR; Fuchs B; Rapp S; Weinauer F; Burkhart J
Cytotherapy; 2006; 8(3):265-76. PubMed ID: 16793735
[TBL] [Abstract][Full Text] [Related]
19. The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft.
Liseth K; Abrahamsen JF; Bjørsvik S; Grøttebø K; Bruserud Ø
Cytotherapy; 2005; 7(4):328-33. PubMed ID: 16162454
[TBL] [Abstract][Full Text] [Related]
20. Systematic factor optimization for cryopreservation of shipped sperm samples of diploid Pacific Oysters, Crassostrea gigas.
Dong Q; Huang C; Eudeline B; Tiersch TR
Cryobiology; 2005 Oct; 51(2):176-97. PubMed ID: 16126190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
